Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells.
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis.
Is it possible to detect active multiple sclerosis plaques using MR thermometry techniques?
JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.
Extensive acute axonal damage in pediatric multiple sclerosis lesions.
Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan.
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
A Further TWEAK to Multiple Sclerosis Pathophysiology.
You're the flight surgeon: multiple sclerosis.
Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility.
Role of myelin sheath energy metabolism in neurodegenerative diseases.
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model.
TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation.
LONGITUDINAL INTENSITY NORMALIZATION IN THE PRESENCE OF MULTIPLE SCLEROSIS LESIONS.
Multiple Sclerosis Autoantigen Myelin Basic Protein Escapes Control by Ubiquitination During Proteasomal Degradation.
Neutrophils Mediate Blood-Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases.
Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program.
Brain networks disconnection in early multiple sclerosis cognitive deficits: An anatomofunctional study.
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis.
Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
Altered transition metal homeostasis in the cuprizone model of demyelination.
Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System.
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis.
Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
Pages
« first
‹ previous
…
465
466
467
468
469
470
471
472
473
…
next ›
last »